Switch View
© EQS Newswire
02.10.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron to present new analyses from and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 38th ECNP Congress 2025
News Preview
Newron to present new analyses from and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 38th European College of Neuropsychopharmacology (ECNP) Congress 2025
New post-hoc analyses highlighting the clinical benefit of evenamide for patients with treatment-resistant schizophrenia (TRS) or those in......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.10.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron präsentiert neue Analysen und Updates zu seinem klinischen Programm zur Bewertung von Evenamide als Zusatztherapie bei Schizophrenie auf dem 38. Kongress des ECNP 2025
News Preview
Newron präsentiert neue Analysen und Updates zu seinem klinischen Programm zur Bewertung von Evenamide als Zusatztherapie bei Schizophrenie auf dem 38. Kongress des European College of Neuropsychopharmacology (ECNP) 2025
Neue Post-hoc-Analysen bestätigen den klinischen Nutzen von Evenamide für Patienten mit behandlungsresistenter Schizophrenie (tr......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon sichert US-Vermarktungsstart für Aflibercept-Biosimilar FYB203 durch Settlement-Vereinbarung mit Regeneron
News Preview
Pressemitteilung // 2. Oktober 2025
Formycon sichert US-Vermarktungsstart für Aflibercept-Biosimilar FYB203 durch Settlement-Vereinbarung mit Regeneron
Formycon und seine Partner haben mit Regeneron eine Vergleichs- und Lizenzvereinbarung für FYB203/AHZANTIVE®1 (Aflibercept-mrbb) abgeschlossen
Die anhängigen Verfahren vor dem US-Bezirksgericht ......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© EQS Newswire
02.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
News Preview
Press Release // October 2, 2025
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon and its partners entered into a settlement and license agreement with Regeneron for FYB203/AHZANTIVE® (Aflibercept-mrbb)
Pending litigation at the U.S. District Court fo......
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
02.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Securities Fraud Class Action Against Semler Scientific, Inc.
News Preview
SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025. Semler Scientific describes itself as a company...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
02.10.2025
ISIN: CA3499331013
Forte Group Holdings Inc.
FGH
LISTED
CSE
Forte Group Closes Private Placement and Complementary Strategic Initiatives, Strengthening Financial Position and Balance Sheet
News Preview
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / October 2, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC:FGHFF)(FSE:7BC0, WKN:A40L1Z)("Forte Group" or the "Company"), a next-generation beverage and nutraceutical company focused on longe...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. INVESTOR ALERT: Kirby McInerney LLP Notifies Semler Scientific, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
News Preview
Kirby McInerney LLP reminds Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ:SMLR) investors of the October 28, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action.
If you purchased or otherwise acquired Semler Scientific securities, have information, or would like to learn more, please contac...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDA...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2025
ISIN: KYG4672N1198
HUTCHMED (China) Ltd
13
LISTED
HKSE
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2025
News Preview
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the European Society for Medical Oncology (“ESMO”) Congress 2025, taking place on...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US26622P1075
Doximity Inc
DOCS
LISTED
NYSE
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
News Preview
Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.
Investors who have continuously held Doximity shares since before June 24, 2021, may have legal rights and are enco...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Class...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration
News Preview
WASHINGTON, Oct. 1, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has agreed on a collaborative framework with the U.S. Food and Drug Administration (FDA) for the resolution of certain disputes regarding HETLIOZ® (tasimelteon) and tradipitant....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
01.10.2025
ISIN: US00404A1097
Acadia Healthcare Company Inc
ACHC
LISTED
NASDAQ
Khrom Capital Sends Letter to Board of Directors of Acadia Healthcare
News Preview
Khrom Capital Management LLC (“Khrom Capital”), which together with its investment funds and affiliates, owns 5.5% of Acadia Healthcare Company, Inc. (Nasdaq: ACHC) (“Acadia” or the “Company”) and is one of the Company’s largest shareholders, today sent a letter to the Company’s Board of Directors reiterating its belief that the Company should pur...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: IE00B91XRN20
Prothena Corporation PLC
PRTA
LISTED
NASDAQ
Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease
News Preview
Prothena Corporation plc (NASDAQ:PRTA), announced today that Bristol Myers Squibb communicated in a press release that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BMS-986446, a potential best-in-class anti-microtubule binding region-tau (anti-MTBR-tau) antibody currently in Phase 2 development for the treatmen...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf Announces Executive Automatic Securities Disposition Plan
News Preview
STAMFORD, Conn., Oct. 1, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that effective as of September 30, 2025, Mr. Joseph F. Lusardi, the Company's Executive Vice Chairman, has established an automatic securiti...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf Announces Executive Automatic Securities Disposition Plan
News Preview
STAMFORD, Conn., Oct. 1, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that effective as of September 30, 2025, Mr. Joseph F. Lusardi, the Company's Executive Vice Chairman, has established an automatic securities disp...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US69366J2006
PTC Therapeutics Inc
PTCT
LISTED
NASDAQ
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
WARREN, N.J., Oct. 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept. 28, 2025, the company approved non-statutory stock options to purchase an aggregate of 19,475 shares of its common stock and 39,060 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upo...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US90337L1089
US Physical Therapy Inc
USPH
LISTED
NYSE
U.S. Physical Therapy Presented at the Jefferies Healthcare Services Conference
News Preview
U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Carey Hendrickson, Chief Financial Officer, participated in the Jefferies Healthcare Services Conference held on September 30, 2025.
About U.S. Physical Therapy, Inc.
F...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: CH0499880968
ADC Therapeutics SA
ADCT
LISTED
NYSE
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
News Preview
LAUSANNE, Switzerland, Oct. 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 162,000 of the Company's common shares to four new employees on October 1, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US48576U2050
Karyopharm Therapeutics Inc
KPTI
LISTED
NASDAQ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEWTON, Mass., Oct. 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 333 restricted stock units (RSUs) to one newly-hired employee. This RSU award was granted as of September 30, 2025 (the "Gran...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, alongside Mass General Brigham, Ariadne Labs, Boston Children’s Hospital, Albert Einstein College of Medicine, the Association of Public Health Laboratories (APHL), Case Western Reserve University, Baylor College of Medicine, and Illumina, today announc...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US98943L1070
Zentalis Pharmaceuticals Inc
ZNTL
LISTED
NASDAQ
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that on October 1, 2025, the Compensation Committee of Zentalis’ Bo...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Investor News: Rosen Law Firm Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – MLTX
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX) resulting from allegations that MoonLake may have issued materially misleading business information to the investing public.
So What: If you purchased MoonLake s...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX Investors Have Opportunity to Join MoonLake Immunotherapeutics Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or f...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US0048901096
Acrivon Therapeutics Inc
ACRV
LISTED
NASDAQ
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 (Acrivon Predictive Precision Proteomics) platform designed to interpr...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
News Preview
Castle Biosciences' Founder, President & CEO Derek Maetzold awarded CEO of the Year by The CEO Magazine...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash
News Preview
Basel, 1 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has commenced a tender offer for all of the outstanding shares of common stock of 89bio, Inc. (89bio) (NASDAQ: ETNB) at a price of $14.50 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain milestone payments of up to an aggregate...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US00972D1054
Akebia Therapeutics Inc
AKBA
LISTED
NASDAQ
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted seven newly-hired employees options to purchase an aggregate of 204,163 shares of Akebia’s common stock on September 30, 2025. The options wer...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US68621F1021
Organogenesis Holdings Inc
ORGO
LISTED
NASDAQ
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
News Preview
CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that third quarter of fiscal year 2025 financ...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US8294011080
Sionna Therapeutics Inc
SION
LISTED
NASDAQ
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
News Preview
WALTHAM, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) pro...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: BE0003818359
Galapagos NV
GLPG
LISTED
EURONEXT
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business
News Preview
Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement:...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US05463X1063
AxoGen Inc
AXGN
LISTED
NASDAQ
Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of Axogen, Inc. (“Axogen” or “the Company”) (NASDAQ: AXGN) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. Axo...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
News Preview
Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM) and a pioneer in clinical genomic testing, today announced an enhancement to the Ambry CARE Program® (CARE), Ambry’s digital platform that streamlines cancer risk assessment and genetic testing workflows. The update integrates breast density into the Tyrer-Cuzick (TC) b...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. (SVRA) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 1, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA)....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 1, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH)....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US9418481035
Waters Corp
WAT
LISTED
NYSE
Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call
News Preview
MILFORD, Mass., Oct. 1, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2025 financial results conference call on Tuesday, November 4th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 1, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR)....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 1, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 1, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD)....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica completes acquisition of Optegra
News Preview
EssilorLuxottica completes acquisition of Optegra...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US16359R1032
Chemed Corp
CHE
LISTED
NYSE
Chemed To Report Third-Quarter 2025 Earnings October 28, Related Conference Call To Be Held On October 29
News Preview
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2025, on Tuesday, October 28, 2025, following the close of trading on the New York Stock Exchange.
Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 29, 2025, to discuss the company's...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
More Unhoused Seniors in Los Angeles County will Find a Home and Access Healthcare Thanks to a $7 Million Partnership with Health Net and Centene Foundation
News Preview
Seniors in Azusa, California will have a home in a new 96-bed care facility, which will offer meals, mental health, medical care, and case management services to address their urgent needs.
SACRAMENTO, Calif., Oct. 1, 2025 /PRNewswire/ -- Health Net, one of Cali...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
News Preview
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US05463X1063
AxoGen Inc
AXGN
LISTED
NASDAQ
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Axogen, Inc. (“Axogen” or “the Company”) (NASDAQ: AXGN) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
01.10.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
News Preview
New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today f...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US37733W2044
GSK plc
GSK
LISTED
NYSE
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
News Preview
GSK plc (LSE/NYSE: GSK) today announced a major update to Vaccine Track, a first-of-its-kind, interactive public data tool for tracking adult immunization activity in the US. Users can now explore vaccination trends across 387 different metro areas* to get insights on adult immunization at the local level. Vaccine Track now also includes a full de...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina launches new business to accelerate technology and data-driven discovery
News Preview
New business focuses on developing data assets, software, and AI to
fuel life science breakthroughs
Expands pharma access to large omics datasets to
advance target discovery and drug development...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US2307701092
Cumberland Pharmaceuticals, Inc.
CPIX
LISTED
NASDAQ
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO
News Preview
Injectable Ibuprofen Approved for Treating Pain & Fever
NASHVILLE, Tenn., Oct. 1 , 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that its ibuprofen injection product, has received reg...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US92556V1061
Viatris Inc
VTRS
LISTED
NASDAQ
Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
PITTSBURGH, Oct. 1, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) will report third quarter 2025 financial results on Thursday, November 6, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to liste...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US38246G1085
GoodRx Holdings, Inc.
GDRX
LISTED
NASDAQ
GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of its brand medication savings solution, RxSmartSaver powered by GoodRx, at Kroger pharmacies nationwide. RxSmartSaver brings medication affordability directly to the pharmacy counter, improving the patient experience while delivering...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US30048L3024
Evofem Biosciences, Inc
EVFM
LISTED
OTC
Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates
News Preview
— First ex-U.S. Regulatory Filing for SOLSOEC® —
— Pharma 1 Targets 1H 2026 Launch in UAE for
SOLOSEC® to Treat Bacterial Vaginosis and Tricho...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Closes Acquisition of Iodine Software, Extending AI Leadership in Healthcare Software
News Preview
Unites industry-leading AI-powered financial and clinical intelligence on Waystar's cloud-based software platform
Expands total addressable market by more than 15%; expected to be accretive to financial profile with highly recurring subscription-based business...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD LAWSUIT ALERT: Levi & Korsinsky Notifies LifeMD, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Investors in Altimmune, Inc. Should Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your Rights - ALT
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Lost Money on Nutex Health Inc.(NUTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
October 28, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SMLR
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Levi & Korsinsky Reminds Lantheus Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 10, 2025 - LNTH
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
